Plus: Novartis will buy allergy-drug developer Excellergy. And in markets, shares of Unity Software and Lumentum Holdings were on the rise. Danny Lewis hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices

my private podcast channel
Plus: Novartis will buy allergy-drug developer Excellergy. And in markets, shares of Unity Software and Lumentum Holdings were on the rise. Danny Lewis hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices